Selected April Publications from BIDMC Faculty

BIDMC Communications mediarelations@bidmc.harvard.edu

APRIL 30, 2019

Building on our culture of collaboration and innovation, our researchers are helping to transform medicine and health care delivery. Below are selected research publications issued in the month of April. 

If you have any questions about the publications or would like to suggest a paper for inclusion, please email mediarelations@bidmc.harvard.edu

 

Would You Refer This Patient With Cancer to a Palliative Care Specialist?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Annals of Internal Medicine – Apr. 2, 2019
BIDMC Authors: Eileen E. Reynolds, Mary K. Buss, Benjamin L. Schlechter, Anjala Tess (Department of Medicine)

What Type of Price Transparency Do We Need in Health Care?
Annals of Internal Medicine – Apr. 2, 2019
BIDMC Author: Ateev Mehrotra (Internal Medicine)

Chronic Diarrhea and Constipation are More Common in Depressed Individuals
Clinical Gastroenterology and Hepatology – Apr. 4, 2019
BIDMC Authors: Sarah Ballou, Jesse Katon, Prashant Singh, Vikram Rangan, Ha Neul Lee, Courtney McMahon, Johanna Iturrino, Anthony Lembo, Judy Nee (Department of Medicine)

Tissue-specific Oncogenic Activity of K-RasA146T
Cancer Discovery – Apr. 5, 2019
BIDMC Authors: Emily J. Poulin, Yi-Jang Lin, Joshua Cook, Christian W. Johnson, Phaedra C Ghazi, Yina Li, Kevin M. Haigis (Department of Medicine, Cancer Research Institute)

Closing the Gender Wage Gap and Achieving Professional Equity in Medicine
JAMA – Apr. 5, 2019
BIDMC Author: Carol K. Bates (Department of Medicine)

miR-147b-mediated TCA Cycle Dysfunction and Pseudohypoxia Initiate Drug Tolerance to EGFR Inhibitors in Lung Adenocarcinoma
Nature Metabolism – Apr. 8, 2019
BIDMC Authors: Wen Cai Zhang, He Huang, Min Yuan, Tanvi Saxena, John M. Asara, Daniel B. Costa, Frank J. Slack (HMS Initiative for RNA Medicine, Department of Pathology, Division of Hematology and Oncology, Division of Signal Transduction)

Patient Readmission Rates for All Insurance Types after Implementation of the Hospital Readmissions Reduction Program
Health Affairs – Apr. 8, 2019
BIDMC Authors: Enrico G. Ferro, Eric A. Secemsky, Rishi K. Wadhera, Eunhee Choi, Jordan B. Strom, Changyu Shen, and Robert W. Yeh (Smith Center for Outcomes Research in Cardiology)

Health Insurance and Mobile Health Devices: Opportunities and Concerns
JAMA – Apr. 11, 2019
BIDMC Authors: Inbar Raber, Robert W. Yeh (Department of Medicine, Smith Center for Outcomes Research in Cardiology)

LLGL2 Rescues Nutrient Stress by Promoting Leucine Uptake in ER+ Breast Cancer
Nature – Apr. 17, 2019
BIDMC Authors: Yasuhiro Saito, John M. Asara, Senthil K. Muthuswamy (Cancer Research Institute)

Raising the Bar for Procedural Competency Among Hospitalists
Annals of Internal Medicine – Apr. 23, 2019
BIDMC Authors: Jonathan T. Crocker, Caleb P. Hale, Anita Vanka, Daniel N. Ricotta, Grace C. Huang (Department of Medicine)

Vulnerabilities in mIDH2 AML Confer Sensitivity to APL-like Targeted Combination Therapy
Cell Research – Apr. 25, 2019
BIDMC Authors: Vera Mugoni, Riccardo Panella, Giulia Cheloni, Ming Chen, Dina Stroopinsky, Jlenia Guarnerio, Emanuele Monteleone, Jonathan David Lee, Lourdes Mendez, Archita Venugopal Menon , Manoj Kumar Bhasin, David Avigan, Letizia Longo, John Gerard Clohessy, Pier Paolo Pandolfi (Cancer Research Institute, Division of Hematology and Hematologic Malignancies)

About Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.

BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit www.bidmc.org.

BIDMC is part of Beth Israel Lahey Health, a new health care system that brings together academic medical centers and teaching hospitals, community and specialty hospitals, more than 4,000 physicians and 35,000 employees in a shared mission to expand access to great care and advance the science and practice of medicine through groundbreaking research and education.